Ascending Dose Study of CT1812 in Healthy Volunteers
Condition(s):Cognitive ImpairmentLast Updated:September 7, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Cognitive ImpairmentLast Updated:September 7, 2016Completed
Condition(s):Anorexia NervosaLast Updated:August 7, 2023Recruiting
Condition(s):Esophageal Adenocarcinoma; Esophagus SCC; Cholangiocarcinoma; Urothelial/Bladder Cancer, Nos; Endometrial CancerLast Updated:March 15, 2024Completed
Condition(s):COVID-19 PandemicLast Updated:October 26, 2023Terminated
Condition(s):Hematopoietic and Lymphoid System Neoplasm; Malignant Solid Neoplasm; Refractory Sclerodermatous Graft Versus Host DiseaseLast Updated:January 30, 2024Suspended
Condition(s):Non-small Cell Lung CancerLast Updated:March 23, 2023Recruiting
Condition(s):StrokeLast Updated:April 14, 2021Unknown status
Condition(s):Atherosclerotic Cardiovascular Disease; Cardiovascular Diseases; Atherosclerosis; Arterial Inflammation; Vascular Diseases; Vascular Disease, Peripheral; Vascular Calcification; High Cholesterol/Hyperlipidemia; Heart Diseases; Heart Attack; Stroke; Cerebrovascular Accident; Carotid Artery Diseases; Carotid Atherosclerosis; Transient Ischemic AttackLast Updated:February 20, 2024Not yet recruiting
Condition(s):OsteoporosisLast Updated:September 29, 2015Completed
Condition(s):Metastatic Colorectal CancerLast Updated:May 11, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.